Save
Email
Print
Share
RSSBrowse News Stories
71 to 80 of 847 stories
view headlines only
-
Key Immune Cell May Play Role in Lung Cancer Susceptibility
September 21, 2012 — New research suggests a key immune cell may play a role in lung cancer susceptibility. Working in mice, they found evidence that the genetic diversity in natural killer cells contributes to whether ... > full story -
Two Studies Could Lead to New Personalized Therapies for Lung Cancer Patients
September 13, 2012 — Lung cancer is a leading cause of death worldwide and is associated with very low survival rates. Two new genome-sequencing studies have uncovered novel genes involved in the deadly disease, as well ... > full story -
In Lung Cancer, Smokers Have 10 Times More Genetic Damage Than Never-Smokers
September 13, 2012 — Lung cancer patients with a history of smoking have 10 times more genetic mutations in their tumors than those with the disease who have never smoked, according to a new ... > full story -
Chemotherapy-Resistant Cancer Stem Cell Could Be 'Achilles' Heel' of Cancer
September 10, 2012 — Scientists have discovered a subpopulation of cells that display cancer stem cell properties and resistance to chemotherapy, and participate in tumor progression. This breakthrough could lead to the ... > full story -
New Potential Targets Discovered for Treating Squamous Cell Lung Cancers
September 9, 2012 — A new study holds out hope that people with the second most common type of lung cancer may one day benefit from targeted therapies that have transformed treatments for other lung cancer patients. ... > full story -
Crizotinib Reduces Tumor Size in Patients With ALK Positive Lung Cancer
September 6, 2012 — Crizotinib is effective in shrinking tumors in patients with anaplastic lymphoma receptor tyrosine kinase positive non-small cell lung cancer, a cancer commonly found in people who never smoked, and ... > full story -
Hispanic Lung Cancer Patients Have Higher Survival Than Non-Hispanic White Patients
September 6, 2012 — Analysis of non-small cell lung cancer (NSCLC) patient records in the California Cancer Registry database during the 20-year period of 1988-2008 indicates that Hispanics/Latinos with NSCLC have a ... > full story -
Standard Chemotherapy Provides Higher Survival Rate Than Experimental in Lung Cancer Patients
September 6, 2012 — Treatment with pemetrexed, carboplatin and bevacizumab followed by maintenance pemetrexed and bevacizumab (Pem+Cb+B) is no better than standard therapy with paclitaxel, carboplatin and bevacizumab ... > full story -
Brain Radiation After Lung Cancer Treatment Reduces Risk of Cancer Spreading
September 6, 2012 — Stage III non-small cell lung cancer patients treated with surgery and/or radiation therapy have a significantly reduced risk of developing brain metastases if they also receive prophylactic cranial ... > full story -
Adding Bavituximab to Second-Line Chemotherapy Doubles Response Rate
September 6, 2012 — Adding the monoclonal antibody bavituximab to docetaxel chemotherapy doubles overall response rate and improves progression-free survival and overall survival in late-stage non-squamous, non-small ... > full story
Search ScienceDaily
Number of stories in archives: 137,075
more 
